X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lipoglycopeptide (151) 151
index medicus (143) 143
humans (135) 135
pharmacology & pharmacy (125) 125
microbiology (115) 115
anti-bacterial agents - pharmacology (110) 110
vancomycin (102) 102
infectious diseases (101) 101
lipoglycopeptides (92) 92
microbial sensitivity tests (82) 82
anti-bacterial agents - therapeutic use (64) 64
telavancin (63) 63
antibiotics (57) 57
resistant staphylococcus-aureus (56) 56
dalbavancin (51) 51
in-vitro activity (46) 46
oritavancin (45) 45
staphylococcus aureus - drug effects (42) 42
infections (41) 41
aminoglycosides - pharmacology (40) 40
animals (40) 40
vancomycin - pharmacology (39) 39
glycopeptides (37) 37
teicoplanin - analogs & derivatives (37) 37
female (36) 36
gram-positive bacterial infections - drug therapy (36) 36
glycopeptides - pharmacology (32) 32
gram-positive bacteria - drug effects (32) 32
male (32) 32
staphylococcus aureus (32) 32
anti-bacterial agents - administration & dosage (31) 31
staphylococcus-aureus (31) 31
gram-positive bacterial infections - microbiology (30) 30
adult (28) 28
aminoglycosides - therapeutic use (28) 28
soft-tissue infections (28) 28
anti-bacterial agents - pharmacokinetics (27) 27
complicated skin (27) 27
mrsa (26) 26
bacteria (25) 25
daptomycin (25) 25
glycopeptide (25) 25
gram-positive bacteria (25) 25
methicillin-resistant staphylococcus aureus - drug effects (25) 25
skin diseases, bacterial - drug therapy (25) 25
middle aged (24) 24
acute bacterial skin (23) 23
methicillin-resistant (23) 23
surveillance (23) 23
treatment outcome (23) 23
internal medicine (22) 22
staphylococcal infections - drug therapy (22) 22
staphylococcal infections - microbiology (22) 22
teicoplanin - pharmacology (22) 22
anti-bacterial agents - adverse effects (21) 21
drug resistance (21) 21
drug therapy (21) 21
efficacy (21) 21
glycopeptides - therapeutic use (21) 21
infectious disease (21) 21
bacteremia (20) 20
enterococcus - drug effects (20) 20
methicillin-resistant staphylococcus aureus (20) 20
pneumonia (20) 20
susceptibility (20) 20
vancomycin resistance (20) 20
aged (19) 19
pharmacokinetics (19) 19
aminoglycosides - administration & dosage (18) 18
antibacterial agents (18) 18
epidemiology (18) 18
once-weekly dalbavancin (18) 18
pathogens (18) 18
skin (18) 18
staphylococcus infections (18) 18
teicoplanin - therapeutic use (18) 18
united states (18) 18
analysis (17) 17
drug resistance in microorganisms (17) 17
drug resistance, bacterial (17) 17
pharmacology (17) 17
skin-structure infections (17) 17
standard therapy (17) 17
td-6424 (17) 17
vancomycin - therapeutic use (17) 17
aminoglycosides - pharmacokinetics (16) 16
antibacterial activity (16) 16
biosynthesis (16) 16
health aspects (16) 16
research (16) 16
resistance (16) 16
staphylococcus aureus infections (16) 16
time factors (16) 16
immunology (15) 15
methicillin resistance (15) 15
staphylococcus - drug effects (15) 15
teicoplanin (15) 15
anti-bacterial agents - chemistry (14) 14
biochemical phenomena, metabolism, and nutrition (14) 14
enterococci (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Enfermedades Infecciosas y Microbiologia Clinica, ISSN 0213-005X, 01/2017, Volume 35, pp. 15 - 21
Dalbavancin is a semisynthetic lipoglycopeptide approved for the treatment of acute skin and soft tissue infections due to Gram-positive microorganisms... 
Breakpoints | Dalbavancin | Lipoglycopeptides | Subrogate value
Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 06/2018, Volume 91, Issue 2, pp. 199 - 204
The in vitro activity of oritavancin was assessed against 44,715 gram-positive pathogens causing infections in European and United States (US) hospitals... 
Lipoglycopeptide | Oritavancin | Gram-positive cocci | LIPOGLYCOPEPTIDES | INFECTIOUS DISEASES | CARE-ASSOCIATED INFECTIONS | INVASIVE INFECTIONS | MICROBIOLOGY | VANCOMYCIN-RESISTANT ENTEROCOCCI | STREPTOCOCCI | ACUTE BACTERIAL SKIN | STAPHYLOCOCCI | US HOSPITALS | SINGLE-DOSE ORITAVANCIN | PATHOGENS | Medical centers | Antibacterial agents
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2018, Volume 62, Issue 3
Dalbavancin activity was assessed against a large collection of Staphylococcus aureus isolates (n = 59,903), including isolates with decreased susceptibility... 
Glycopeptides | Lipoglycopeptides | Vancomycin-intermediate S. aureus | lipoglycopeptides | vancomycin-intermediate S. aureus | glycopeptides | METAANALYSIS | MINIMUM INHIBITORY CONCENTRATION | SKIN-STRUCTURE INFECTIONS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 01/2018, Volume 61, Issue 1, pp. 286 - 304
Lipophilic substitution on vancomycin is an effective strategy for the development of novel vancomycin analogues against drug-resistant bacteria by enhancing... 
GLYCOPEPTIDE ANTIBIOTICS | METHICILLIN-RESISTANT | LIPOGLYCOPEPTIDES | REDUCED SUSCEPTIBILITY | BACTERIA | CHEMISTRY, MEDICINAL | CELL VIABILITY | GRAM-POSITIVE INFECTIONS | INTERMEDIATE | TELAVANCIN | TETRAZOLIUM SALT | Index Medicus
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 10/2018, Volume 38, Issue 10, pp. 990 - 998
Journal Article
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 01/2011, Volume 52, Issue 1, pp. 31 - 40
Background. Telavancin is a lipoglycopeptide bactericidal against gram-positive pathogens. Methods. Two methodologically identical, double-blind studies (0015... 
INFECTIOUS DISEASES | INFECTIONS | VENTILATOR-ASSOCIATED PNEUMONIA | MEMBRANE | INTENSIVE-CARE UNITS | MICROBIOLOGY | IMMUNOLOGY | RESISTANT STAPHYLOCOCCUS-AUREUS | INTEGRITY | LIPOGLYCOPEPTIDE | IN-VITRO ACTIVITY | EPIDEMIOLOGY | NOSOCOMIAL PNEUMONIA
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 1/2011, Volume 52, Issue 1, pp. 31 - 40
Journal Article
Journal Article
Chemical Communications, ISSN 1359-7345, 03/2016, Volume 52, Issue 25, pp. 4667 - 4670
A novel theranostic divalent vancomycin analog using a planar 1,8-diazapyrene moiety as a rigid scaffold exhibits potent and selective antibacterial activity... 
LIPOGLYCOPEPTIDES | BACTERIA | PEPTIDOGLYCAN | MULTIVALENT VANCOMYCIN | ANTIBACTERIAL ACTIVITY | BIOSYNTHESIS | ORITAVANCIN | STAPHYLOCOCCUS-AUREUS | ENTEROCOCCI | MICROSCOPY | CHEMISTRY, MULTIDISCIPLINARY | Analogs | Antibiotics | Imaging | Bacteria | Mammals | Glycopeptides | Antiinfectives and antibacterials | Strain
Journal Article
Enfermedades Infecciosas y Microbiologia Clinica, ISSN 0213-005X, 01/2017, Volume 35, pp. 28 - 32
Multiresistant Gram-positive infections continue to pose a major clinical challenge and the development of new antibiotics is always desirable. Dalbavancin is... 
Lipoglycopeptide | In vivo | Animal models | Dalbavancin
Journal Article
Current Opinion in Infectious Diseases, ISSN 0951-7375, 12/2014, Volume 27, Issue 6, pp. 471 - 478
PURPOSE OF REVIEWVancomycin has been the cornerstone of treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections. This review describes new... 
Lipoglycopeptide | Antibiotic treatment | Oxazolidinone | Methicillin-resistant Staphylococcus aureus | Antibiotic resistance | UNITED-STATES | INFECTIOUS DISEASES | antibiotic treatment | VITRO PHARMACOKINETIC/PHARMACODYNAMIC MODEL | VANCOMYCIN-INTERMEDIATE | methicillin-resistant Staphylococcus aureus | EOSINOPHILIC PNEUMONIA | RESISTANT STAPHYLOCOCCUS-AUREUS | oxazolidinone | ACUTE BACTERIAL SKIN | CEFTAROLINE FOSAMIL | antibiotic resistance | lipoglycopeptide | SKIN-STRUCTURE INFECTIONS | GRAM-POSITIVE INFECTIONS | SURVEILLANCE PROGRAM | Linezolid | Severity of Illness Index | Drug Administration Routes | Staphylococcal Infections - drug therapy | Vancomycin - administration & dosage | Skin Diseases, Bacterial - immunology | Staphylococcal Infections - immunology | Glycopeptides - administration & dosage | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Skin Diseases, Bacterial - drug therapy | Cephalosporins - administration & dosage | Oxazolidinones - administration & dosage | Lipoglycopeptides | Microbial Sensitivity Tests | Anti-Bacterial Agents | Skin Diseases, Bacterial - prevention & control | Tetrazoles - administration & dosage | Cost-Benefit Analysis | Staphylococcal Infections - prevention & control | Drug Therapy, Combination | Acetamides - administration & dosage | Index Medicus
Journal Article
ACS Chemical Biology, ISSN 1554-8929, 03/2019, Volume 14, Issue 3, pp. 356 - 360
Glycopeptide antibiotics are used to treat severe multidrug resistant infections caused by Gram-positive bacteria. Dalbavancin is a second generation... 
ACYLTRANSFERASES | LIPOGLYCOPEPTIDE | GLYCOPEPTIDE ANTIBIOTIC A40926 | TEICOPLANIN | BIOCHEMISTRY & MOLECULAR BIOLOGY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.